Anixa Biosciences, Inc. (ANIX)
5.06
-0.16
(-3.07%)
USD |
NASDAQ |
Dec 09, 16:00
5.17
+0.11
(+2.17%)
Pre-Market: 08:21
Anixa Biosciences EPS Diluted (Quarterly): -0.0695 for July 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Puma Biotechnology, Inc. | 0.1736 |
| GT Biopharma, Inc. | -0.8268 |
| ImmunityBio, Inc. | -0.071 |
| Lexeo Therapeutics, Inc. | -0.3326 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.28M |
| Total Expenses (Quarterly) | 2.258M |
| Enterprise Value | 149.56M |
| Earnings Yield | -6.81% |
| Normalized Earnings Yield | -6.808 |